March 12, 2026
4 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
Pyoderma gangrenosum is a difficult-to-treat wound disease that may soon have promising new therapies.In this Beneath the Surface video interview, Joel M. Gelfand, MD, MSCE, FAAD, the James J. Leyden Professor of Clinical Investigation and professor of dermatology and epidemiology at University of Pennsylvania’s Perelman School of Medicine and Healio Dermatology’s Chief Medical
March 12, 2026
4 min watch
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .

Chronic wounds are an immense burden for patients. If left untreated, chronic wounds can be life-threatening, making effective…

CLEVELAND — For the first time in decades, targeted therapies to treat cutaneous lupus erythematosus are advancing through the…

DENVER — Adults with active psoriatic arthritis and obesity had improvements in disease activity, physical function, weight loss…

CLEVELAND — Researchers are beginning to understand the pathogenesis of dermatomyositis, leading to new, targeted therapies for…

CLEVELAND — Using laser and light devices to treat autoimmune or connective tissue disease sequelae, such as scarring, requires…

DESTIN, Fla. — New treatments have improved outcomes in lupus, but preventing disease in the early stages remains elusive,…